Clinical outcome of chronic myeloid leukemia patients who switch from first-line therapy with a second generation tyrosine kinase inhibitor to an alternative TKI
| Autor: | Ma, Chen-En, Ghosh, Sunita, Leyshon, Catherine, Blosser, Nikki, Dersch-Mills, Deonne, Jupp, Jennifer, Savoie, Lynn, Liew, Elena, Jamani, Kareem * |
|---|---|
| Zdroj: | In Leukemia Research December 2021 111 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect